Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for postoperative analgesia after hemorrhoidectomy
ChiCTR2500100394Phase 4Not yet recruiting
- Sponsor
- Taikang Tongji Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in hemorrhoid (2 arms), sponsored by Taikang Tongji Hospital. Primary endpoints: Time to first postoperative compression of the analgesic pump and Opioid consumption within 72 hours postoperatively. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2500100394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100394.